FDA Chief Makary Pushes OTC Drug Expansion, Addresses GLP-1 Compounding and China Competition
FDA Commissioner Marty Makary outlined plans to expand over-the-counter drug access, crack down on unlawful GLP-1 compounding, and address the U.S. falling behind China in early-stage drug development.